المؤلفون: Pier Luigi Zinzani, Julien Depaus, P. Valagussa, Simonetta Viviani, Patrice Carde, Laurianne Clément-Filliatre, Jonathan Douxfils, Marc André, Olivier Casasnovas, Massimo Federico, Pauline Brice, Nicolas Mounier, Alessandro M. Gianni, Paolo G. Gobbi, Jehan Dupuis, Catherine Fortpied, Martin Hutchings, Emilio Iannitto, Monica Bellei, Marian Heczko, Alessandro Rambaldi, Josette Brière

المساهمون: Andre M.P.E., Carde P., Viviani S., Bellei M., Fortpied C., Hutchings M., Gianni A.M., Brice P., Casasnovas O., Gobbi P.G., Zinzani P.L., Dupuis J., Iannitto E., Rambaldi A., Briere J., Clement-Filliatre L., Heczko M., Valagussa P., Douxfils J., Depaus J., Federico M., Mounier N., UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie

المصدر: Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298Test
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)

مصطلحات موضوعية: 0301 basic medicine, BEACOPP, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Procarbazine, 0302 clinical medicine, International Prognostic Index, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Original Research, Etoposide, Randomized Controlled Trials as Topic, Hazard ratio, Neoplasms, Second Primary, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hodgkin Disease, Dacarbazine, Vincristine, 030220 oncology & carcinogenesis, Disease Progression, secondary cancers, Female, medicine.drug, Adult, medicine.medical_specialty, ABVD, Hodgkin lymphoma, overall survival, progression-free survival, Adolescent, Vinblastine, Risk Assessment, Transplantation, Autologous, lcsh:RC254-282, 03 medical and health sciences, Bleomycin, Young Adult, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Progression-free survival, Cyclophosphamide, Aged, business.industry, Clinical Cancer Research, progression‐free survival, 030104 developmental biology, Clinical Trials, Phase III as Topic, Doxorubicin, Prednisone, business, Stem Cell Transplantation

وصف الملف: STAMPA; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99be92d20b893ec3b515374f66c11fcTest
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29aTest

المؤلفون: Carla M.L. van Herpen, Marie Vinches, Catherine Fortpied, Éva Remenár, Petr Szturz, Cyril Abdeddaim, John S. Stewart, Jan B. Vermorken

المصدر: European Journal of Cancer, 156, 109-118
European Journal of Cancer, 156, pp. 109-118
European journal of cancer

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Time Factors, Databases, Factual, medicine.medical_treatment, Docetaxel, Gastroenterology, Risk Assessment, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Feeding tube, Aged, Retrospective Studies, business.industry, Squamous Cell Carcinoma of Head and Neck, Head and neck cancer, Hazard ratio, Induction chemotherapy, Middle Aged, medicine.disease, Dysphagia, Progression-Free Survival, Radiation therapy, Europe, Oncology, Clinical Trials, Phase III as Topic, Head and Neck Neoplasms, Disease Progression, Female, Human medicine, Fluorouracil, medicine.symptom, Cisplatin, business, PF Regimen, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b9beeda7988f0755536e301dad808aTest
https://pubmed.ncbi.nlm.nih.gov/34425403Test

المؤلفون: Anat Gafter-Gvili, Bernice Oberman, Maria Gomes da Silva, Marinus H. J. van Oers, Peter Dreger, Umberto Vitolo, Michele Ghielmini, Ofer Shpilberg, Mathias Witzens-Harig, Thomas M. Habermann, Liat Vidal, Laurence S. Freedman, Carmit Rubin, Hailun Li, Catherine Fortpied, Andrea Evangelista, Sami Bousseta, Ruth Pettengell, Gilles Salles

المساهمون: Electrical Engineering University of Leeds, Service d'hématologie [Hôpital Edouard Herriot - HCL], Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon ( HCL ) -Hospices Civils de Lyon ( HCL ), Centre de Recherche en Cancérologie de Lyon ( CRCL ), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Science for Life Laboratory Uppsala, Department of Medical Biochemistry and Microbiology, Uppsala University, Hematology, Academic Medical Center [Amsterdam] ( AMC ), University of Amsterdam [Amsterdam] ( UvA ) -University of Amsterdam [Amsterdam] ( UvA ), European Organisation for Research and Treatment of Cancer [Bruxelles] ( EORTC ), European Cancer Organisation [Bruxelles] ( ECCO ), Innere Medizin V, Medizinische Universitäts-Klinik und Poliklinik, Heidelberg University Hospital [Heidelberg], Instituto Português de Oncologia de Lisboa Francisco Gentil, China Agricultural University ( CAU ), Shanghai Jiao Tong University [Shanghai], Clinical Haematology

المصدر: European journal of cancer (Oxford, England : 1990)
European journal of cancer (Oxford, England : 1990), 2017, 76 (17), pp.216-225
European journal of cancer (Oxford, England, 76, 216-225. Elsevier Limited

مصطلحات موضوعية: Male, Oncology, Cancer Research, Follicular lymphoma, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Follicular, Randomized Controlled Trials as Topic, Aged, 80 and over, Hazard ratio, Induction Chemotherapy, Middle Aged, Survival Rate, Vincristine, 030220 oncology & carcinogenesis, Meta-analysis, Female, Rituximab, medicine.drug, Adult, medicine.medical_specialty, Maintenance, Antineoplastic Agents, Induction Phase, Infections, Disease-Free Survival, Maintenance Chemotherapy, Immunocompromised Host, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Overall survival, Humans, Adverse effect, Cyclophosphamide, Aged, Proportional Hazards Models, business.industry, Patient data, medicine.disease, Surgery, Doxorubicin, Multivariate Analysis, Prednisone, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98e169ea2c5ae06e30694e469de7179Test
https://hal.archives-ouvertes.fr/hal-01568667Test